BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36380479)

  • 21. Combining faecal immunochemical testing with blood test results for colorectal cancer risk stratification: a consecutive cohort of 16,604 patients presenting to primary care.
    Withrow DR; Shine B; Oke J; Tamm A; James T; Morris E; Davies J; Harris S; East JE; Nicholson BD
    BMC Med; 2022 Mar; 20(1):116. PubMed ID: 35287679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasia.
    Parekh M; Fendrick AM; Ladabaum U
    Aliment Pharmacol Ther; 2008 Apr; 27(8):697-712. PubMed ID: 18248653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for colorectal cancer with immunochemical faecal occult blood tests.
    Faivre J; Dancourt V; Lejeune C
    Dig Liver Dis; 2012 Dec; 44(12):967-73. PubMed ID: 22898146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening.
    Parra-Blanco A; Gimeno-García AZ; Quintero E; Nicolás D; Moreno SG; Jiménez A; Hernández-Guerra M; Carrillo-Palau M; Eishi Y; López-Bastida J
    J Gastroenterol; 2010 Jul; 45(7):703-12. PubMed ID: 20157748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review.
    Burch JA; Soares-Weiser K; St John DJ; Duffy S; Smith S; Kleijnen J; Westwood M
    J Med Screen; 2007; 14(3):132-7. PubMed ID: 17925085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective cohort study of compliance with faecal immunochemical tests for colorectal cancer screening in Hong Kong.
    Wong MC; Ching JY; Lam TY; Luk AK; Hirai HW; Griffiths SM; Chan FK; Sung JJ
    Prev Med; 2013 Sep; 57(3):227-31. PubMed ID: 23732241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interval colorectal cancers after negative faecal immunochemical test in a 13-year screening programme.
    Zorzi M; Hassan C; Senore C; Capodaglio G; Turrin A; Narne E; Mussato A; Rizzato S; Chinellato E; Zamberlan S; Repici A; Rugge M
    J Med Screen; 2021 Jun; 28(2):131-139. PubMed ID: 32393153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diagnostic accuracy of the faecal immunochemical test for colorectal cancer in risk-stratified symptomatic patients.
    D'Souza N; Hicks G; Benton SC; Abulafi M
    Ann R Coll Surg Engl; 2020 Mar; 102(3):174-179. PubMed ID: 31697171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.
    Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y
    Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Faecal immunochemical testing for adults with symptoms of colorectal cancer attending English primary care: a retrospective cohort study of 14 487 consecutive test requests.
    Nicholson BD; James T; Paddon M; Justice S; Oke JL; East JE; Shine B
    Aliment Pharmacol Ther; 2020 Sep; 52(6):1031-1041. PubMed ID: 32677733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for colorectal cancer and advanced colorectal neoplasia in kidney transplant recipients: cross sectional prevalence and diagnostic accuracy study of faecal immunochemical testing for haemoglobin and colonoscopy.
    Collins MG; Teo E; Cole SR; Chan CY; McDonald SP; Russ GR; Young GP; Bampton PA; Coates PT
    BMJ; 2012 Jul; 345():e4657. PubMed ID: 22833618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.
    Schreuders EH; Grobbee EJ; Nieuwenburg SAV; Kapidzic A; van Roon AHC; van Vuuren AJ; Lansdorp-Vogelaar I; Spijker WWJ; Izelaar K; Bruno MJ; Kuipers EJ; Spaander MCW
    Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):622-631. PubMed ID: 31196734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunochemical fecal occult blood tests for colorectal cancer screening: Point-of-care tests are not tenable for a quality-assured program].
    Haug U; Becker N
    Dtsch Med Wochenschr; 2016 May; 141(10):729-31. PubMed ID: 27176068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of interval cancers in faecal immunochemical test colorectal screening programmes in Italy.
    Giorgi Rossi P; Carretta E; Mangone L; Baracco S; Serraino D; Zorzi M;
    J Med Screen; 2018 Mar; 25(1):32-39. PubMed ID: 28195508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One-sample quantitative and two-sample qualitative faecal immunochemical tests for colorectal cancer screening: a cross-sectional study in China.
    Wang L; Chen H; Zhu Y; Lu M; Wang Y; Chen X; Ma W; Du L; Chen W
    BMJ Open; 2022 May; 12(5):e059754. PubMed ID: 35589365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
    Tinmouth J; Lansdorp-Vogelaar I; Allison JE
    Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positivity rates and performances of immunochemical faecal occult blood tests at different cut-off levels within a colorectal cancer screening programme.
    Faivre J; Dancourt V; Manfredi S; Denis B; Durand G; Gendre I; Bidan JM; Jard C; Levillain R; Jung S; Viguier J; Dorval E
    Dig Liver Dis; 2012 Aug; 44(8):700-4. PubMed ID: 22542582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-risk symptoms and quantitative faecal immunochemical test accuracy: Systematic review and meta-analysis.
    Pin Vieito N; Zarraquiños S; Cubiella J
    World J Gastroenterol; 2019 May; 25(19):2383-2401. PubMed ID: 31148909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for colorectal cancer using the faecal occult blood test, Hemoccult.
    Hewitson P; Glasziou P; Irwig L; Towler B; Watson E
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD001216. PubMed ID: 17253456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case-control study to evaluate efficacy of screening for faecal occult blood.
    Lazovich D; Weiss NS; Stevens NG; White E; McKnight B; Wagner EH
    J Med Screen; 1995; 2(2):84-9. PubMed ID: 7497161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.